Diabetes mellitus research hub

A randomised, double-blind, placebo controlled, parallel group, multi-centre trial in adult subjects with newly diagnosed type 1 diabetes mellitus investigating the effect of Verapamil SR on preservation of beta-cell function (VER-A-T1D)

This study looks at whether a drug called Verapamil can help people newly diagnosed with type 1 diabetes keep their bodies making some insulin. Researchers want to see if it preserves the 'beta cells' that produce insulin, which could be an important step for future treatments.